Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (231-240 of 424) with videos related to

Pageof 43
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Methodology phase II clinical trial in cancerF M Muggia, M Rozencweig, M J Staquet, et al.
American Journal of Obstetrics and Gynecology|June 1, 1977
Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinomaF M Muggia, G Chia, L J Reed, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Progressive paresthesias after cessation of therapy with very high-dose cisplatinS M Grunberg, S Sonka, L L Stevenson, et al.
Cancer Treatment Reports|January 1, 1978
High-dose methotrexate, not a conventional treatmentR Catane, V H Bono, A C Louie, et al.
Surgery, Gynecology & Obstetrics|September 1, 1987
Surgical treatment for advanced epithelial carcinoma of the ovaryU Beller, E M Beckman, F M Muggia, et al.
Surgery, Gynecology & Obstetrics|January 1, 1982
Surgical correction of ectropion of the anal mucosaH Y Kaplan, H Freund, M Muggia-Sullam, et al.
Cancer|October 1, 1975
Ectopic placental proteins in nontrophoblastic tumors. Serial measurements following chemotherapyF M Muggia, S W Rosen, B D Weintraub, et al.
Radiology|July 1, 1973
The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changesL D Napoli, H H Hansen, F M Muggia, et al.
Anticancer Research|May 1, 1991
High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primaryI Gill, P Guaglianone, S M Grunberg, et al.
Ecancermedicalscience|June 29, 2016
Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?Alexandra Silverton, Roy A Raad, Leah Katz, et al.
Pageof 43

Showing results (231-240 of 424) with videos related to

Sort By:
Pageof 43
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Methodology phase II clinical trial in cancerF M Muggia, M Rozencweig, M J Staquet, et al.
American Journal of Obstetrics and Gynecology|June 1, 1977
Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinomaF M Muggia, G Chia, L J Reed, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Progressive paresthesias after cessation of therapy with very high-dose cisplatinS M Grunberg, S Sonka, L L Stevenson, et al.
Cancer Treatment Reports|January 1, 1978
High-dose methotrexate, not a conventional treatmentR Catane, V H Bono, A C Louie, et al.
Surgery, Gynecology & Obstetrics|September 1, 1987
Surgical treatment for advanced epithelial carcinoma of the ovaryU Beller, E M Beckman, F M Muggia, et al.
Surgery, Gynecology & Obstetrics|January 1, 1982
Surgical correction of ectropion of the anal mucosaH Y Kaplan, H Freund, M Muggia-Sullam, et al.
Cancer|October 1, 1975
Ectopic placental proteins in nontrophoblastic tumors. Serial measurements following chemotherapyF M Muggia, S W Rosen, B D Weintraub, et al.
Radiology|July 1, 1973
The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changesL D Napoli, H H Hansen, F M Muggia, et al.
Anticancer Research|May 1, 1991
High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primaryI Gill, P Guaglianone, S M Grunberg, et al.
Ecancermedicalscience|June 29, 2016
Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?Alexandra Silverton, Roy A Raad, Leah Katz, et al.
Pageof 43